Related Experiment Video

Updated: May 27, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Linking immunity to atherosclerosis: implications for vascular pharmacology--a tribute to Göran K. Hansson

Yong-Jian Geng1, Lena Jonasson

  • 1Center of Cardiovascular Biology and Atherosclerosis Research, University of Texas Medical School at Houston, TX 77030, USA. yong-jian.geng@uth.tmc.edu

Vascular Pharmacology
|November 29, 2011
PubMed

Insights

Recent advances in understanding atherosclerosis pathogenesis, particularly vascular immunity and inflammation, are paving the way for novel prevention and treatment strategies for this chronic arterial disease.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Vascular Biology

Background:

  • Atherosclerosis is a chronic arterial disease leading to severe complications like heart attack and stroke.
  • Understanding its pathogenesis is crucial for developing effective interventions.
  • Vascular immunity and inflammation play a key role in disease progression and regression.

Purpose of the Study:

  • To review recent discoveries in basic and translational sciences regarding atherosclerosis pathogenesis.
  • To highlight advances in clinical medicine for treating atherosclerotic vascular diseases.
  • To connect the role of vascular immunity and inflammation to atherosclerosis complications.

Main Methods:

  • Literature review of basic, translational, and clinical research.
  • Synthesis of current knowledge on atherosclerosis pathogenesis.
  • Focus on the interplay between vascular immunity and inflammation.

Main Results:

  • Significant progress in understanding the fundamental mechanisms of atherosclerosis.
  • Emerging strategies for prevention and treatment based on new insights.
  • Identification of vascular immunity and inflammation as critical factors.

Conclusions:

  • Enhanced understanding of atherosclerosis pathogenesis offers new therapeutic avenues.
  • Targeting vascular immunity and inflammation holds promise for managing atherosclerotic vascular diseases.
  • Continued research is vital for combating life-threatening complications.

More Related Videos

Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Flow Cytometry Analysis of Immune Cells Within Murine Aortas15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...